Literature DB >> 31400503

Structured introduction of retroperitoneoscopic donor nephrectomy provides a high level of safety and reduces the physical burden for the donor compared to an anterior mini incision: A cohort study.

Martina Koch1, Sylvia Kroencke2, Jun Li3, Christian Wiessner4, Björn Nashan5.   

Abstract

INTRODUCTION: A major goal in living donor kidney transplantation is to reduce the physical burden for the donor. Key-hole surgery for donor nephrectomy is a safe procedure, but concerns regarding donor safety during the learning phase might be the reason for surgeons' reluctance to change to a minimal invasive approach.
MATERIAL AND METHODS: We analyzed the first 100 retroperitoneoscopic donor nephrectomies (RPDN) performed at our institution and compared the results to the last 50 mini incision donor nephrectomies (MIDN) regarding donor and recipient outcome, and analyzed the learning curves of RPDN.
RESULTS: The learning phase of RPDN was very short with significantly shorter operative times compared to MIDN (118 vs. 175 min, p < 0.001) and significantly fewer surgical complications (p = 0.03). RPDN patients rated the physical burden (p = 0.01) as lower, and they felt less bothered by the surgical scar (p = 0.03).
CONCLUSION: Introducing RPDN is safe, even during the learning phase of the surgeons. Changing surgical technique from MIDN to RPDN reduces the surgical burden of the procedure. Our study might encourage more transplant centres to adopt a minimally invasive approach.
Copyright © 2019 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Learning curve; Living donation; Retroperitoneoscopic donor nephrectomy; Safety; Surgical skills

Mesh:

Year:  2019        PMID: 31400503     DOI: 10.1016/j.ijsu.2019.07.038

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  1 in total

1.  Hernia after retroperitoneoscopic adrenalectomy, case report.

Authors:  Christian T J Magyar; Christian A Nebiker
Journal:  Gland Surg       Date:  2020-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.